Highest Debt to EBITDA Ratio in the Health Care Equipment Industry Detected in Shares of Insulet (PODD, ARAY, IVC, HRC, BSX)
Below are the three companies in the Health Care Equipment industry with the highest debt to EBITDA ratios. This ratio indicates how many years of EBITDA would be necessary in order to pay back all the debt (assuming Debt and EBITDA are constant). Typically, this ratio is considered to be alarming when it is greater than 3.0 but this can vary and should be looked at within the context of the industry.
Insulet ranks highest with a a debt to EBITDA ratio of 76.6. Accuray is next with a a debt to EBITDA ratio of 25.8. Invacare ranks third highest with a a debt to EBITDA ratio of 16.0.
Hill-Rom Holdings follows with a a debt to EBITDA ratio of 11.1, and Boston Scientific rounds out the top five with a a debt to EBITDA ratio of 7.3.
SmarTrend recommended that subscribers consider buying shares of Boston Scientific on March 14th, 2016 as our technology indicated a new Uptrend was in progress when shares hit $18.01. Since that recommendation, shares of Boston Scientific have risen 30.5%. We continue to monitor Boston Scientific for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: highest debt to ebitda ratio insulet accuray invacare hill-rom holdings Boston SCientific